Frédéric Morinet

1.5k total citations
24 papers, 1.1k citations indexed

About

Frédéric Morinet is a scholar working on Infectious Diseases, Genetics and Epidemiology. According to data from OpenAlex, Frédéric Morinet has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Genetics and 8 papers in Epidemiology. Recurrent topics in Frédéric Morinet's work include Virus-based gene therapy research (10 papers), Parvovirus B19 Infection Studies (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Frédéric Morinet is often cited by papers focused on Virus-based gene therapy research (10 papers), Parvovirus B19 Infection Studies (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Frédéric Morinet collaborates with scholars based in France, Japan and Switzerland. Frédéric Morinet's co-authors include M Bisson, Sylvie Pillet, Xavier Mariette, Joël Gozlan, C Griscelli, Stéphane Blanche, Catherine Scieux, Pierre Bordigoni, Patrick Niaudet and M. Hirn and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Clinical Infectious Diseases.

In The Last Decade

Frédéric Morinet

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Morinet France 15 406 369 359 193 165 24 1.1k
Jean‐Thierry Aubin France 20 877 2.2× 483 1.3× 440 1.2× 58 0.3× 91 0.6× 43 1.2k
James T. Grace United States 20 458 1.1× 343 0.9× 595 1.7× 220 1.1× 208 1.3× 64 1.5k
J. H. Joncas Canada 22 621 1.5× 458 1.2× 611 1.7× 82 0.4× 193 1.2× 62 1.3k
Michelle L. Paulson United States 8 259 0.6× 282 0.8× 105 0.3× 147 0.8× 822 5.0× 11 1.1k
Dominique De Wit Belgium 19 385 0.9× 185 0.5× 159 0.4× 116 0.6× 1.5k 9.1× 33 2.0k
Gerlinde Obermoser Austria 19 474 1.2× 185 0.5× 101 0.3× 93 0.5× 930 5.6× 30 1.6k
Christine Spalding United States 8 260 0.6× 291 0.8× 148 0.4× 139 0.7× 958 5.8× 10 1.2k
A. Graham Bird United Kingdom 19 282 0.7× 158 0.4× 255 0.7× 163 0.8× 718 4.4× 31 1.5k
SangKon Oh United States 18 393 1.0× 210 0.6× 337 0.9× 139 0.7× 1.9k 11.3× 26 2.4k
K Groeneveld Netherlands 13 313 0.8× 110 0.3× 125 0.3× 93 0.5× 420 2.5× 22 1.1k

Countries citing papers authored by Frédéric Morinet

Since Specialization
Citations

This map shows the geographic impact of Frédéric Morinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Morinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Morinet more than expected).

Fields of papers citing papers by Frédéric Morinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Morinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Morinet. The network helps show where Frédéric Morinet may publish in the future.

Co-authorship network of co-authors of Frédéric Morinet

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Morinet. A scholar is included among the top collaborators of Frédéric Morinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Morinet. Frédéric Morinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morinet, Frédéric, Sylvie Pillet, Marianne Leruez‐Ville, & Nathalie Aladjidi. (2015). Une question de terrain : signification de la persistance de l'ADN du parvovirus B19.. PubMed. 19(4). 173–177. 1 indexed citations
2.
Morinet, Frédéric, et al.. (2013). Oxygen tension level and human viral infections. Virology. 444(1-2). 31–36. 25 indexed citations
3.
Servant‐Delmas, Annabelle, Jean‐Jacques Lefrère, Frédéric Morinet, & Sylvie Pillet. (2010). Advances in Human B19 Erythrovirus Biology. Journal of Virology. 84(19). 9658–9665. 69 indexed citations
4.
Pillet, Sylvie, Thomas Höfer, Florence Nguyen‐Khac, et al.. (2004). Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology. 327(1). 1–7. 45 indexed citations
5.
Scieux, Catherine, Valérie Garrait, Gèrard Socié, et al.. (2000). Resistant Herpes Simplex Virus Type 1 Infection: An Emerging Concern after Allogeneic Stem Cell Transplantation. Clinical Infectious Diseases. 31(4). 927–935. 123 indexed citations
6.
Chevret, Sylvie, Catherine Scieux, Valérie Garrait, et al.. (1999). Usefulness of the Cytomegalovirus (CMV) Antigenemia Assay for Predicting the Occurrence of CMV Disease and Death in Patients with AIDS. Clinical Infectious Diseases. 28(4). 758–763. 24 indexed citations
7.
Ribaud, Patricia, et al.. (1999). Successful Treatment of Adenovirus Disease with Intravenous Cidofovir in an Unrelated Stem‐Cell Transplant Recipient. Clinical Infectious Diseases. 28(3). 690–691. 77 indexed citations
8.
Vassias, Isabelle, Uriel Hazan, Yanne Michel, et al.. (1998). Regulation of Human B19 Parvovirus Promoter Expression by hGABP (E4TF1) Transcription Factor. Journal of Biological Chemistry. 273(14). 8287–8293. 21 indexed citations
9.
Mikol, Jacqueline, et al.. (1996). HERPES VIRUS-LIKE DNA SEQUENCES IN PRIMARY NON HODGKIN LYMPHOMAS OF THE CENTRAL NERVOUS SYSTEM. Journal of Neuropathology & Experimental Neurology. 55(5). 623–623. 2 indexed citations
10.
Leruez‐Ville, Marianne, et al.. (1995). Le parvovirus B19 et l'hématopoïèse. Hématologie. 1(6). 1 indexed citations
11.
Leleu, Ghislaine, et al.. (1995). Les pneumonies à adénovirus. 6(1). 18–22. 4 indexed citations
12.
Molina, Jean‐Michel, F Ferchal, Sylvie Chevret, et al.. (1994). Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection. AIDS. 8(1). 27–34. 29 indexed citations
13.
Karmochkine, Marina, Jean‐Michel Molina, Catherine Scieux, et al.. (1994). Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS. The American Journal of Medicine. 97(2). 196–197. 7 indexed citations
14.
Mariette, Xavier, F. Agbalika, Marie‐Thérèse Daniel, et al.. (1993). Detection of human t lymphotropic virus type i tax gene in salivary gland epithelium from two patients with sjögren's syndrome. Arthritis & Rheumatism. 36(10). 1423–1428. 60 indexed citations
15.
Vassias, Isabelle, et al.. (1993). An in situ hybridization technique for the study of B19 human parvovirus replication in bone marrow cell cultures. Journal of Virological Methods. 44(2-3). 329–338. 6 indexed citations
16.
Defer, Christine, et al.. (1992). Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS. 6(7). 659–664. 36 indexed citations
17.
Fischer, Alain, Stéphane Blanche, J. Le Bidois, et al.. (1991). Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation. New England Journal of Medicine. 324(21). 1451–1456. 282 indexed citations
18.
Mariette, Xavier, et al.. (1991). Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. The American Journal of Medicine. 90(3). 286–294. 120 indexed citations
19.
20.
Morinet, Frédéric, et al.. (1989). Occurrence of Epstein-Barr Virus Deoxyribonuclease Enzyme Activity-Neutralizing Antibodies. Intervirology. 30(1). 36–43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026